1-20 of 282
Keywords: Dopamine
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Neuroendocrinology (2024) 114 (5): 483–510.
Published Online: 21 December 2023
... the SuMN manifest this influence has not been delineated. This study investigated the effect of SuMN tyrosine hydroxylase (TH) (rate-limiting enzyme in dopamine synthesis) knockdown (THx) on peripheral fuel metabolism. Methods: SuMN-THx was accomplished using a virus-mediated shRNA to locally knockdown TH...
Journal Articles
Neuroendocrinology (2024) 114 (3): 263–278.
Published Online: 21 November 2023
...)-ventral tegmental area (VTA) dopamine (DA) neural reward circuit, thereby uncovering a possible central mechanism underlying EA’s actions in improving obesity and IR. Methods: We randomly allocated 45 Wistar male rats to five groups (normal, model, EA, chemogenetic activation, chemogenetic suppression...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (2016) 103 (3-4): 300–314.
Published Online: 24 July 2015
... of progesterone could protect dopaminergic neurons already exposed to MPTP (experiment 2). We measured progesterone effects on various dopaminergic markers [dopamine and its metabolites, dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2)] and on neuroactive steroids in both plasma...
Journal Articles
Journal Articles
Neuroendocrinology (2012) 96 (2): 152–161.
Published Online: 25 April 2012
... to in the content or advertisements. Progesterone Progestin receptors Dopamine Crosstalk National Institutes of Health (NIH) 10.13039/100000002 The dominant, model system for studying the cellular mechanisms of progesterone action in the brain remains the estradiol (E 2 )/progesterone...
Journal Articles
Neuroendocrinology (2012) 95 (4): 332–343.
Published Online: 21 March 2012
... intracerebroventricular infusion of Low-PRL lowered body weight and epididymal fat pads by increasing hypothalamic dopamine levels that reduced serum prolactin levels and potentiated leptin signaling. However, High-PRL slightly exacerbated energy dysregulation, decreased hypothalamic dopamine levels, and elevated serum...
Journal Articles
Journal Articles
Neuroendocrinology (2012) 95 (1): 47–55.
Published Online: 25 October 2011
..., instructions or products referred to in the content or advertisements. Glucocorticoid 11β-HSD2 Developmental programming Anxiety Depression Serotonin Dopamine UKRI (UK Research and Innovation) Low birth weight and other indicators of reduced fetal growth are associated...
Journal Articles
Neuroendocrinology (2011) 94 (2): 148–157.
Published Online: 08 June 2011
... and CIS at mRNA (by semiquantitative and real-time RT-PCR) and protein (by Western blot only for TH, ERα and PRs) levels, and dopamine and DOPAC (by high-performance liquid chromatography) contents in the mediobasal hypothalamus (MBH) 24 h after luteolysis induced by a PGF2α analogue (cloprostenol, 25 µg...
Journal Articles
Neuroendocrinology (2010) 91 (3): 256–267.
Published Online: 29 January 2010
...F.B. Rowther; A. Richardson; R.N. Clayton; W.E. Farrell Dopamine (DA) agonists are the primary treatment choice for prolactinoma, effectively suppressing prolactin expression and reducing tumour size. However, the intracellular pathway(s) through which either DA or its agonists impact...
Journal Articles
Neuroendocrinology (2010) 91 (1): 48–55.
Published Online: 26 November 2009
... role in drug-induced anorexia caused by amphetamines. It is also the most sensitive site in the hypothalamic monoaminergic system that involves dopamine (DA) and epinephrine (EPI). DA antagonist, stereotaxically placed in this site, can stimulate feeding, and specific injections of DA or EPI can result...
Journal Articles
Journal Articles
Journal Articles
Neuroendocrinology (1995) 62 (2): 198–206.
Published Online: 09 April 2008
... this paradigm, we also determined the potential modulating role of secretagogues reportedly released by IL-1β, such as dopamine, corticosterone and progesterone. A second series of experiments involved the long-term (3-5 days) icv infusion of IL-1β to identify the influence of gender on the pattern of PRL...
Journal Articles
Neuroendocrinology (1995) 62 (2): 147–154.
Published Online: 09 April 2008
.... Neurohypophysis innervation Melanotropes Periventricular nucleus Dopamine Neurohypophysis Intermediate lobe Tuberoinfundibular neurons Cell Biology and Pharmacology of the Pituitary Neuroendocrinology 1995:62:147-154 John L. Goudreaua William M. Fal/sb Keith J. Lookingland3 Kenneth E. Moore3 Departments...
Journal Articles